Making viagra: From impotence to erectile dysfunction

Medicating Modern America: Prescription Drugs in History

Volumn , Issue , 2007, Pages 229-252

  Fishman, Jennifer R ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900212414     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (79)

1. Nicholas B. King, "Infectious Disease in a World of Goods" (PhD dissertation, HarvardUniversity, 2001).
2. Adele E. Clarke, Janet K. Shim, Laura Mamo, Jennifer Ruth Fosket, and Jennifer R. Fishman, "Biomedicalization: Technoscientific Transformations ofHealth, Illness, and U.S. Biomedicine," American Sociological Review 68 (2003), 161-194.
3. Barbara L. Marshall and Stephen Katz, "Forever Functional: Sexual Fitnessand the Ageing Male Body," Body and Society 8 (2002), 43-70.
4. Adele E. Clarke, Disciplining Reproduction: Modernity, American Life Sciences, and the Problems of Sex (Berkeley, 1998).
5. Nelly Oudshoorn, Beyond the Natural Body: An Archeology of Sex Hormones (NewYork, 1994).
6. Marshall and Katz, "Forever Functional," 52.
7. Marshall and Katz, "Forever Functional," 52.
8. Alfred C. Kinsey et al., Sexual Behavior in the Human Male (New York, 1948).
9. William H. Masters and Virginia Johnson, Human Sexual Inadequacy (Boston, 1970).
10. William H. Masters and Virginia E. Johnson, Human SexualResponse (Boston, 1966).
11. Leonore Tiefer, Sex Is Not a Natural Act and Other Essays (Boulder, 1995).
12. Francois Ewald, "Norms, Discipline, and the Law," Representations 30 (1990), 138-161.
13. Sheri Hite, The Hite Report (New York, 1976).
14. John Bancroft, "Erectile Impotence: Psyche or soma?" International Journalof Andrology 5 (1982), 353-355.
15. Helen Singer Kaplan, The New Sex Therapy: Active Treatmentsof Dysfunctions (New York, 1974).
16. Richard F. Spark, Robert A. White, and Peter B. Connolly, "Impotence Is Not Always Psychogenic," Journal of the American Medical Association 243 (1980).
17. Robert N. Butler and Mitzi L. Davis, Loveand Sex After 60, Revised ed. (New York, 1988).
18. Leonore Tiefer, "In Pursuit of the Perfect Penis: The Medicalization ofMale Sexuality," American Behavioral Scientist 29 (1986), 579-599.
19. Georges Canguilhem, Machine and Organism (New York, 1992).
20. Georges Canguilhem, On the Normal and the Pathological, trans. Carolyn R. Fawcett (Dordrecht, 1978).
21. Bruno Latour, Science in Action: How to Follow Scientists and EngineersThrough Society (Cambridge, MA, 1987).
22. Leonore Tiefer, "The Medicalization of Impotence-Normalizing Phallocentrism," Gender & Society 8 (1994), 363-377.
23. Stanley E. Althof, "Quality of Life and Erectile Dysfunction," Urology 59 (2002), 803-810;
24. Mark S. Litwin, Robert J. Nied, and Nasreen Dhanani, "Health-Related Quality of Life in Men with Erectile Dysfunction," Journal of General Internal Medicine 13 (1998), 159-169;
25. S. N. Seidman S. P. Roose, M. A. Menza, R. Shabsigh, and R. C. Rosen, "Sildenafil improved erectile dysfunction and qualityof life in men with comorbid mild-to-moderate depression," ACP Journal Club 137 (2002), 21;
26. Jean M.B. Woodward, Steven L. Hass, and Paul J. Woodward, "Reliability and Validity of the Sexual Life Quality Questionnaire," Quality of Life Research 11 (2002), 365-377.
27. Tiefer, "In Pursuit of the Perfect Penis."
28. Spark, White, and Connolly, "Impotence."
29. H. Ghanem T. Sherif, T. Abdel-Gawad, T. Asaad, "Shortterm use of intracavernous vasoactive drugs in the treatment of persistent psychogenicerectile dysfunction," International Journal of Impotence Research 10 (1998), 211-214.
30. Tiefer, "The Medicalization of Impotence."
31. L. Incrocci, W. C. J. Hop, and A. K. Slob, "Visual erotic and vibrotactilestimulation and intracavernous injection in screening men with erectile dysfunction: a 3 year experience with 406 cases," International Journal of Impotence Research 8 (1996), 227-232.
32. D. G. Hatzichristou, "Sildenafil Citrate: Lessons Learned from 3 Years ofClinical Experience," International Journal of Impotence Research 14 (2002), S42-S52;
33. Somboon Leungwattanakji, Vincent Flynn, and Wayne J. G. Hellstrom, "Intracavernosal Injection and Intraurethral Therapy for Erectile Dysfunction," Urologic Clinics of North America 28 (2001), 343-354;
34. D. L. Rowland, H. S. M. Boedhoe, G. Dohle, A. K. Slob, "Intracavernosal self-injection therapy in menwith erectile dysfunction: satisfaction and attribution in 119 patients," International Journal of Impotence Research 11 (1999), 145-151.
35. Annemarie Mol, The Body Multiple: Ontology in Medical Practice (Durham, NC, 2002).
36. T. G.W. Steel, H. van Langen, H. Wijktra, E. J. Meuleman, "Penile Duplex Pharmaco-Ultrasonography Revisited: Revalidation of the Parameters of the Cavernous Arterial Response," Journal of Urology 169 (2003), 216-220.
37. Tiefer, "The Medicalization of Impotence."
38. R. J. Krane, I. Goldstein, and I. S. DeTejada, "Impotence," New EnglandJournal of Medicine 321 (1989), 1649-1659.
39. NIH Consensus Development Panel on Impotence, "Impotence: NIH Consensus Conference," Journal of the American Medical Association 270 (1993).
40. National Institute of Health, "Consensus Development Conference Statementon Impotence," International Journal of Impotence Research 5 (1992).
41. NIH Consensus Development Panel on Impotence, "Impotence," 83, emphasis in original.
42. NIH Consensus Development Panel on Impotence, "Impotence," 89.
43. Tiefer, "In Pursuit of the Perfect Penis."
44. Tiefer, "The Medicalization of Impotence."
45. J. LoPicollo, "Direct Treatment of Sexual Dysfunction," in Handbook of Sex Therapy, ed. J. LoPicollo and P. LoPicollo (New York, 1978).
46. Tiefer, Sex Is Not a Natural Act.
47. NIH Consensus Development Panel on Impotence, "Impotence," 85.
48. Michael Bury, "Health, Ageing, and the Lifecourse," in Health, Medicineand Society: Key Theories, Future Agendas, ed. Simon Williams, Jonathan Gabe, and Michael Calnan (London, 2000), 87-105;
49. Carl I. Cohen, "Old Age, Genderand Physical Activity: The Biomedicalization of Aging," Journal of Sport History 18 (1991), 64-80;
50. Carroll L. Estes and Elizabeth A. Binney, "The Biomedicalizationof Aging: Dangers and Dilemmas," The Gerontologist 29 (1989), 587-596;
51. Mike Featherstone and Mike Hepworth, "The Mask of Ageing and the PostmodernLife Course," in The Body: Social Process and Cultural Theory.
52. Mike Featherstone, Mike Hepworth, and Bryan S. Turner (London, 1991), 371-189;
53. Marshall and Katz, "Forever Functional."
54. National Institute of Health, "Consensus Statement on Impotence," 85.
55. Hatzichristou, "Sildenafil Citrate," S43.
56. Masters and Johnson, Human Sexual Response.
57. T. F. Lue, "Hemodynamics of Erection in the Monkey," Journal of Urology 130 (1983), 1237-1241.
58. J. Rajfer, W. J. Aronson, P. A. Bush, F. J. Dorey, and L. J. Ignarro, "Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Noradrenergic, Noncholinergic Neurotransmission," New England Journal of Medicine 326 (1992), 90-94.
59. Christian G. Stief, Stefan Uckert, Armin J. Becker, Michael C. Truss, and Udo Jonas, "The Effect of the Specific Phosphodiesterase (PDE) Inhibitors onHuman and Rabbit Cavernous Tissue in Vitro and in Vivo," Journal of Urology 159 (1998), 1390-1393.
60. A. L. Burnett, "Role of Nitric Oxide in the Physiology of Erection," Biological Reproduction 52 (1995), 485;
61. A. L. Burnett, C. J. Lowenstein, D. S. Bredt, T. S. K. Chang, and S. H. Snyder, "Nitric Oxide: A Physiologic Mediatorof Penile Erection," Science 257 (1992); 41;
62. P. A. Bush, W. J. Aronson, M. B. Georgette, J. Rajfer, and L. J. Ignarro, "Nitric Oxide Is a Potent Relaxant ofHuman and Rabbit Corpus Cavernosum," Journal of Urology 147 (1992), 1650;
63. F. Trigo-Rocha, W. J. Aronson, M. Hohenfeller, L. J. Ignarro, J. Rajfer, and T. F. Lue, "Nitric Oxide and cGMP: Mediators of Pelvic Nerve-Stimulated Erection in Dogs," American Journal of Physiology 264 (1993), H419-H422;
64. A.W. Zorgniottiand E. F. Lizza, "Effect of Large Doses of the Nitric Oxide Precursor, L-arginine, on Erectile Dysfunction," International Journal of Impotence Research 6 (1994), 33-36.
65. Jacob Rajfer, "From the Lab to theClinic," Journal of Urology 159 (1998), 1792;
66. John Leland et al., "A Pill for Impotence?" Newsweek, November 17, 1997, 62-68, and interview data 10/21/01.
67. Stephen A. Ballard, Clive J. Gingell, Kim Tang, Leigh A. Turner, Mary E. Price, and Alasdair M. Naylor, "Effects of Sildenafil on the Relaxation of HumanCorpus Cavernosum Tissue in Vitro and on the Activities of Cyclic NucleotidePhosphodiesterase Isozymes," Journal of Urology 159 (1998), 2164-2171.
68. Alex T. Chuang, John D. Strauss, Richard A. Murphy, and William D. Steers, "Sildenafil, a Type-5 cGMP Phosphodiesterase Inhibitor, SpecificallyAmplifies Endogenous cGMP-Dependent Relaxation in Rabbit Corpus CavernosumSmooth Muscle in Vitro," Journal of Urology 160 (1998), 257-261.
69. Harry M. Marks, The Progress of Experiment: Science and TherapeuticReform in the United States, 1900-1990 (New York, 1997).
70. Mitradev Booleil, Michael J. Allen, Stephen A. Ballard, Sam Gepi-Attee, Gary J. Muirhead, Alasdair M. Naylor, Ian H. Osterloh, and Clive Gingell, "Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesteraseinhibitor for the treatment of penile erectile dysfunction," International Journal ofImpotence Research 8 (1996), 47-52.
71. R. P. Allen, J. K. Smolev, R. M. Engel, and C. B. Brendler, "Comparison ofRigiScan and Formal Nocturnal Penile Tumescence Testing in the Evaluation ofErectile Rigidity," Journal of Urology 149 (1993), 1265-1268;
72. Ian Eardley, Peter Ellis, Mitradev Booleil, and Maria Wulff, "Onset and Duration of Action of Sildenafil Citrate fro the treatment of Erectile Dysfunction," British Journal of ClinicalPharmacology 53 (2002), 61S-65S;
73. I. Goldstein, S. Auerbach, H. Padma-Nathan, J. Rajfer, W. Fitch III, L. Schmitt, and Alprostadil Alfadex Group, "Axial penile rigidityas primary efficacy outcome during multi-institutional dose titration clinicaltrials with alprostadil alfadex in patients with erectile dysfunction," International Journal of Impotence Research 12 (2000), 205-211.
74. Irwin Goldstein et al., "Oral Sildenafilin the Treatment of Erectile Dysfunction," New England Journal of Medicine 338 (1998), 1397-1404.
75. Pfizer Labs, "VIAGRA (Sildenafil citrate): Confidence inTreating ED," (New York, 2000).
76. Pfizer Labs, "What Every Man (and Woman) Should Know: VIAGRA Pamphlet" (New York, 1998).
77. Goldstein et al., "Oral Sildenafil in the Treatment of Erectile Dysfunction."
78. Jeffrey Norris, "On the Road withMolecular Motors," Newsbreak: News for the UCSF Campus Community, May 9, 2003, 1, 4.
79. Jean-Paul Gaudilliere and Ilana Lowy, eds., The Invisible Industrialist: Manufacturers and the Construction of Scientific Knowledge (London, 1998).